Outcomes of Circuit Training and Low Carbohydrates Diet in the Young Obese Male in KSA

March 9, 2021 updated by: faizan kashoo, PT, Majmaah University

Effect of Circuit Training With Low-carbohydrate Diet on Body Composition, Cardiometabolic Indices, and Exercise Capacity in Young Males With Mild to Moderate Obesity in Saudi Arabia

Obesity is one of the common public problems that its prevalence increase incredibly in the last three decades in KSA. Thirty obese males aged 20 to 39 years will participate in the study. The participants will be evaluated on skinfold thickness, percent of body fat, lipid profile, and exercise capacity. All participants will perform a circuit training of aerobic and resistance exercises and be instructed to follow a low carbohydrate diet for eight weeks.

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Riyadh
      • Majmaah, Riyadh, Saudi Arabia, 11952
        • Majmaah University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 39 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Obese young male subjects with a mass index between BMI >30 kg/m2 and 40 kg/m2).
  2. Subjects ages range from 20 to 39 years.
  3. Previously sedentary, defined as no strength training and less than 150 minutes of brisk walking or moderate exercise per week and < less than 60 minutes of vigorous exercise per week in the preceding 6 months.
  4. Only subjects who are nonsmokers.
  5. Subjects who are not taking insulin.
  6. Had no evidence or history of coronary artery disease.

Exclusion Criteria:

  1. Subjects were excluded if they reported a history of heart disease, respiratory conditions, stroke, diabetes, recent cancer, other life-threatening illness, or any condition that limited their ability to engage in moderate-intensity exercise.
  2. Smoking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
The participants will receive circuit training exercise and dietary intervention.

circuit training exercise start with 5 minutes of warming-up then followed by a 30-minute conditioning protocol formed 20 minutes of aerobic exercise and 10 minutes of resisted exercise. The cool-down period is doing in form of walking on a treadmill in low intensity for 5 minutes.

Aerobic exercise will be performed on an electronically-braked cycle ergometer (Quinton Excalibur, QuintonInstrument Company, Bothell, WA). resistance exercise (RT) in the form of eight different exercises will be performed during each workout: military press, leg extension, bench press, standing leg curl (ankle weights), lateral pull-down, dumbbell triceps push-down, dumbbell seated biceps curl, and sit-ups (abdominal curls).

The participant will do 10 minutes for Aerobic exercise followed by 10 minutes of resistance exercise then 10 minutes for Aerobic exercise. This cycle training will perform five days per week for eight weeks.

The diet will be tailor-made for the individual for the body type and obesity in consultation with the nutritionist.
Active Comparator: Control group
The participants will be only involved in dietary intervention.
The diet will be tailor-made for the individual for the body type and obesity in consultation with the nutritionist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiometabolic index
Time Frame: 12 weeks
High-density lipoprotein, low-density lipoprotein, triglycerides, and total cholesterol will be evaluated through a blood sample from the participants at the start and at the end of 12 weeks of intervention.
12 weeks
Exercise capacity
Time Frame: 12 weeks
The renowned modified sub-maximal treadmill exercise test,which is the leading indicator of EC,was done to calculate maximum oxygen uptake (VO2max). The test began with a warm-up at a speed of 2.7 km/h for five minutes, andthe speed was increasedevery three minutes until the participantexerted the maximum effort and stopped upon exhaustion.
12 weeks
Body Weight
Time Frame: 12 weeks
Measured in kilograms
12 weeks
Height
Time Frame: 12 weeks
Measured in meters
12 weeks
Body mass index
Time Frame: 12 weeks
Measured in kg/m^2
12 weeks
Waist circumference
Time Frame: 12 weeks
Measured in centimeters
12 weeks
Hip circumference
Time Frame: 12 weeks
Measured in centimeters
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 11, 2017

Primary Completion (Actual)

December 20, 2020

Study Completion (Actual)

December 25, 2020

Study Registration Dates

First Submitted

March 5, 2021

First Submitted That Met QC Criteria

March 9, 2021

First Posted (Actual)

March 12, 2021

Study Record Updates

Last Update Posted (Actual)

March 12, 2021

Last Update Submitted That Met QC Criteria

March 9, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • MUREC-Apr.11/COM-2017/15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

The Data will be available when the article gets published in a journal.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Circuit training exercise

3
Subscribe